Global Non Opioid Pain Treatment Market is Estimated to Witness High Growth Owing to Increasing Preference for Alternatives to Opioid Medications
The global non opioid pain treatment market primarily includes drugs, devices, and other therapies used for relieving pain without using opioid medications. Some common non opioid therapies include acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), lidocaine patches, capsaicin creams, triptans etc. These help relieve both chronic and acute pain from conditions like back pain, arthritis, migraines etc. without the addiction and side effects risks associated with opioids. The need for alternative therapies is increasing due to growing awareness about the opioid crisis stemming from overprescription and misuse of opioids.
Global non opioid pain treatment market is estimated to be valued at USD 78.89 billion in 2024 and is expected to reach USD 140.56 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.
Key Takeaways
Key players operating in the global non opioid pain treatment are Acro Metal Stamping, Manor Tool Manufacturing Company, DH Industries, Inc., Kenmode, Inc., Klesk Metal Stamping Co, Clow Stamping Company, Goshen Stamping Company, Tempco Manufacturing Company, Inc, Interplex Holdings Pte. Ltd., CAPARO, Nissan Motor Co., Ltd, AAPICO Hitech Public Company Limited, Gestamp, Ford Motor Company, Arconic Corporation, American Axle Manufacturing Holdings, Inc, CIE Automotive S.A., AAPICO Hitech Public Company Limited, Wiegel Tool Works, Inc., and Boker’s, Inc.
The Global non opioid pain treatment marketprovides significant opportunities for players involved in developing novel drug formulations, medical devices and other therapeutics. Growing prevalence of pain-causing conditions and improving access to healthcare also support market growth.
Several companies are expanding their global footprint through collaborations and acquisitions to better serve markets across major countries/regions including North America, Asia Pacific, Europe etc.
Market Drivers
The primary driver for the Global Non Opioid Pain Treatment Market Size and Trends pain treatment market is the increasing preference for alternatives to opioid medications owing to growing awareness about opioid addiction and side effects risks. Stringent regulations restricting opioid prescriptions in several countries are also encouraging the development and adoption of non-addictive therapies. Other factors like rising geriatric population prone to joint pain, growing incidence of lifestyle diseases and improving availability of analgesics also support market gains.
PEST Analysis
Political: There is an increased focus by governments worldwide on curbing the opioid crisis by promoting the use of non-opioid alternatives for pain management. Various regulations have been introduced to encourage development of novel non-opioid therapies.
Economic: The high costs associated with the opioid crisis have compelled governments as well as private insurance companies to support investments into development and adoption of affordable non-opioid treatment options. Growing healthcare expenditure on chronic pain is also boosting market growth.
Social: Heightened awareness about risks of opioid addiction and overdose deaths has led to a shift in patient preference towards safer non-opioid therapies. This trend is being further driven by support from advocacy groups and health organizations.
Technological: Significant R&D investments have enabled development of novel therapeutic mechanisms and delivery methods for non-opioid pain management. Advancements in fields of neuroscience, biologics and digital technologies are expanding the pipeline of potential non-opioid therapies.
The market is primarily concentrated in North America and Western Europe due to strong awareness, healthcare expenditure and presence of major market players in these regions. North America alone accounted for more than 40% of global market value in 2024 owing to the rising epidemic of prescription opioid abuse and deaths in the US.
Asia Pacific is the fastest growing regional market projected to expand at over 6% CAGR during the forecast period. This can be attributed to growing accessibility to advanced treatments coupled with a large patient population suffering from pain in developing Asian countries like India and China.
Discover the Report for More Insights, Tailored to Your Language:
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)
Comments
0 comment